Popular on EntSun
- Jazz Fusion Legend Bob Holz To Release Album With Larry Coryell - 343
- Bald Guy Greetings Launches Bold New Postcard Line Celebrating Over-the Top (and Often Delusional) Confidence - 123
- Tec-Masters to Support In-Space Testing of Honda Regenerative Fuel Cell Technology on the International Space Station - 118
- Retirement Income Specialist Daniel Rondberg Joins Tom Hegna on the Exciting New Season of "Financial Freedom with Tom Hegna" - 111
- The Villages Welcomes NexGen Laser Pain and Rehab Centers—Revolutionizing Pain Management with MLS Laser Technology - 102
- LIB Large-Scale Walk-In Test Chamber Full Process Delivery: MIL-STD-810H Chambers Enable Extreme Environment Testing - 101
- Food Logistics Names Puga Sankara Founder CEO of Smart Gladiator LoadProof as Recipient of 2025 Rock Stars of the Supply Chain Award
- DTFPrinter.com Launches to Revolutionize the Custom Transfer Printing Experience for Crafters and Creators
- Sanger Industrial Development Corporation Launches Workforce Grant to Strengthen Career and Technical Education
- Family Estrangement on the Rise: Therapist Offers Support, Perspective, and Community for Those Affected
Similar on EntSun
- Large Strategic Investment from Global Medical Device Manufacturer to Support Clinics Treating Suicidal Depression and PTSD: NRx: (Stock Symbol: NRXP)
- $300 Million in Milestones; Double-Digit Royalties; Neurospa LOI for Expansion of International Psychiatry Clinics plus NDA Filed with FDA on New Drug
- Dentaluxe's New Website Launch!
- $300 Million in Milestones Plus Tiered Double-Digit Royalties to License & Distribute NRX-100 Drug: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Restoration Dental Launches New Website to Enhance Patient Experience
- OneSolution Dental Implant Centers Announces All-on-X Digital Workflow Master Course in Palm Beach, FL
- Milestone Merger Payment with Predictive Oncology to Advance AI-Driven Biomarker Discovery & Precision Medicine in Cancer & Beyond: Stock Symbol: RENB
- $15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB
- $27 Million Funding; Coverage on Sanjay Gupta/CNN for Treatment of Suicidal Depression; Nasdaq Tier Uplisting: NRx Pharmaceuticals: Stock Symbol: NRXP
- Performentor, LLC Announces 2025 Unleash People Energy® Award Winners
Provenance Bio Announces Results for Recombinant Protein Demonstrating Cell Adhesion Functionality that Can Replace Animal-Derived Proteins
EntSun News/11025936
SAN DIEGO - EntSun -- Provenance Bio, an alternative protein company, announced today that its hydroxylated type I collagen protein demonstrates proof of function by matching the cell adhesion strength of fibronectin, providing promising scalable and sustainable protein solutions across various sectors, including pharmaceuticals.
Microbial-based systems for protein production can make proteins at large manufacturing scales, however, functional animal proteins which undergo post translational modifications (PTMs), remain challenging to these expression systems. Provenance's proprietary precision fermentation platform represents a major biotechnological achievement by enabling cost-effective, sustainable, and scalable recombinant solutions for high value markets. Moreover, and equally important, Provenance Bio's full-length hydroxylated type I collagen protein demonstrates cell adhesion properties comparable to fibronectin, a principal protein used for cell culturing in research and development and pharmaceutical production.
Key Findings:
More on EntSun News
The global market for cell adhesion proteins is rapidly expanding, driven by innovations in cell therapies, cultured meat development, biomaterials, and animal-free products. Provenance Bio's precision fermentation techniques have enabled the production of high-value recombinant collagen and gelatin at scale, positioning the company as a key player in the transition to sustainable protein solutions.
About Provenance Bio's Precision Fermentation Platform
Provenance Bio utilizes a unique compartment within the microbial host cell to produce and modify recombinant animal protein without the use of any animal products. The system enables precise and high-yielding protein expression and post-translational modifications (the addition of certain functional groups to the protein, such as hydroxylation), for the production of bioactive proteins at scale. Additionally, the platform supports product customization to meet specifications such as protein length, bloom strength, and viscosity for a wide range of applications.
About Cell Adhesion Proteins
Cell adhesion proteins, part of the extracellular matrix (ECM), are essential to cell and tissue cultures which are widely used in the life sciences and biomedical research and development. These proteins, e.g. laminin, fibronectin, and collagen are used for coating the cell culture vessels to enhance cell attachment and to stimulate differentiation, migration, structural support and cellular communication, to ultimately mimic the natural behavior of the studied cells. According to Grand View Research Report, the global cell culture protein surface coatings market was valued at USD 826.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2023 to 2030. Stem cell therapy and regenerative medicine are two major fields that are driving the industry growth. Animal derived protein sources have dominated the global industry, however ethical and religious views are driving demand for animal-free components.
More on EntSun News
About Provenance Bio
Provenance is an alternative protein company pioneering molecular biology tools for sustainable products. The company's proprietary micro-compartmentalization protein expression platform represents the future of biomanufacturing. For further information, visit: https://provenance.bio or email info@provenance.bio
Microbial-based systems for protein production can make proteins at large manufacturing scales, however, functional animal proteins which undergo post translational modifications (PTMs), remain challenging to these expression systems. Provenance's proprietary precision fermentation platform represents a major biotechnological achievement by enabling cost-effective, sustainable, and scalable recombinant solutions for high value markets. Moreover, and equally important, Provenance Bio's full-length hydroxylated type I collagen protein demonstrates cell adhesion properties comparable to fibronectin, a principal protein used for cell culturing in research and development and pharmaceutical production.
Key Findings:
- Provenance Bio's unique expression system produced hydroxylated, functional, and bioidentical collagen proteins
- Provenance's hydroxylated collagen proteins promote cell adhesion at a strength equivalent to traditionally used fibronectin in cultured human fibroblast cells
- Provenance collagen also performs head-to-head with human collagen and fibronectin when coated on tissue culture plates demonstrating similar adherence and dissociation with fibroblast cells
- Provenance Bio's collagen protein is being produced at an efficiency that will be cost competitive with animal proteins
More on EntSun News
- Lyricalmar Set To Release Powerful New Ep "MARCHIVES" May 16
- Charleston, SC - ACSEC offers Rain Barrels Through Annual Program
- Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees
- Ink Godz Tattoos Redefines Body Art in St. Petersburg & Largo with Premium Custom Ink Experiences
- HEAVY HITTERS Support Two Dog Rescues in Huntington, NY
The global market for cell adhesion proteins is rapidly expanding, driven by innovations in cell therapies, cultured meat development, biomaterials, and animal-free products. Provenance Bio's precision fermentation techniques have enabled the production of high-value recombinant collagen and gelatin at scale, positioning the company as a key player in the transition to sustainable protein solutions.
About Provenance Bio's Precision Fermentation Platform
Provenance Bio utilizes a unique compartment within the microbial host cell to produce and modify recombinant animal protein without the use of any animal products. The system enables precise and high-yielding protein expression and post-translational modifications (the addition of certain functional groups to the protein, such as hydroxylation), for the production of bioactive proteins at scale. Additionally, the platform supports product customization to meet specifications such as protein length, bloom strength, and viscosity for a wide range of applications.
About Cell Adhesion Proteins
Cell adhesion proteins, part of the extracellular matrix (ECM), are essential to cell and tissue cultures which are widely used in the life sciences and biomedical research and development. These proteins, e.g. laminin, fibronectin, and collagen are used for coating the cell culture vessels to enhance cell attachment and to stimulate differentiation, migration, structural support and cellular communication, to ultimately mimic the natural behavior of the studied cells. According to Grand View Research Report, the global cell culture protein surface coatings market was valued at USD 826.5 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.29% from 2023 to 2030. Stem cell therapy and regenerative medicine are two major fields that are driving the industry growth. Animal derived protein sources have dominated the global industry, however ethical and religious views are driving demand for animal-free components.
More on EntSun News
- Baltimore Author Crafts Space Opera Where Human Questions Outshine Galactic Scale
- Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned
- OpsVeda Announces Launch of TariffSight, the World's First Comprehensive Platform to Address Tariff-Driven Challenges
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
About Provenance Bio
Provenance is an alternative protein company pioneering molecular biology tools for sustainable products. The company's proprietary micro-compartmentalization protein expression platform represents the future of biomanufacturing. For further information, visit: https://provenance.bio or email info@provenance.bio
Source: Provenance Bio
0 Comments
Latest on EntSun News
- Students Celebrate Earth Month and Learn About the Lifecycle of Trees
- Earth Day Gets Bloody in Brooklyn with Satirical Short Film: Don't Litter in Prospect Park!!
- DivsFeed.com Launches: Digital Magazine Spotlighting Human Integrity, Connection, and Impact
- Electives Appoints DraftKings' CPO Linda Aiello to Board Amid Record Quarter
- Blue Ocean Business School's Deputy Dean Delivers Keynote Address at India Blockchain Summit
- AdvisorVault's Consolidated 17a-4 D3P Service® Full Feature Set Available
- Most Common Car Accidents In America
- Kl Allen Issues A Fashion Industry "warning" With New Streetwear Couture Menswear Collection
- 810 Entertainment offers 'Graduation Party Packages' to SWFL seniors, families
- Co-Creating the Future of ePaper: ZKONG and E Ink at Touch Taiwan 2025
- New York Times Exposé Vindicates CCHR: ADHD Isn't Biological, Says Watchdog
- HISTORIC FIRST The First Belief System In Human History To Formally Enshrine The Innate Divinity Of The Infant As Civilization's Central Moral Axis
- Stuck in Place? Why Homeowners Are Building Up Instead of Moving Out
- Crafting the Sound of VS Pop™: The Vision of CR Srikanth
- "Light" by Brian WF Tobin Follows Jesus as a 23-Year-Old Navigating the Darker Side of New York City
- Ikebana Reflections Launches on iPhone and iPad, Expanding the World's First Ikebana Art App Across the Apple Ecosystem
- Oliver Sean's "Devil is Back" Dominates Global Charts Once Again with Remastered Release
- Boston Industrial Solutions, Inc., introduces Rubber and Foam Printing Ink
- FeelWise to Exhibit at ATD 2025 International Conference & EXPO in Washington, DC
- Webinar Announcement: Mexico's Evolving AML/CFT Environment: FATF Review and FTO Designations